Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis

被引:6
|
作者
McLinden, Taylor [1 ]
Moodie, Erica E. M. [1 ]
Hamelin, Anne-Marie [1 ]
Harper, Sam [1 ]
Rossi, Carmine [1 ]
Walmsley, Sharon L. [2 ,3 ]
Rourke, Sean B. [4 ,5 ,6 ]
Cooper, Curtis [7 ]
Klein, Marina B. [8 ,9 ]
Cox, Joseph [1 ,8 ,9 ]
机构
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West, Montreal, PQ H3A 1A2, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada
[4] Ontario HIV Treatment Network, Toronto, ON, Canada
[5] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[6] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[7] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[8] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada
[9] CIHR Canadian HIV Trials Network, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
Methadone treatment; Severe food insecurity; HIV; Hepatitis C virus; Propensity score matching; INFECTED INDIVIDUALS; C VIRUS; PREVALENCE; PEOPLE;
D O I
10.1016/j.drugalcdep.2017.12.031
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Severe food insecurity (FI) is common among individuals living with HIV-hepatitis C virus (HCV) co-infection. We hypothesize that the injection of opioids is partly responsible for the association between injection drug use and severe FI. Therefore, this analysis examines whether methadone maintenance treatment for opioid dependence is associated with a lower risk of severe Fl. Methods: We used biannual data from the Canadian Co-infection Cohort (N = 608, 2012-2015). Methadone treatment (exposure) was self-reported and severe FI (outcome) was measured using the Household Food Security Survey Module. To quantify the association between methadone treatment and severe FI, we estimated an average treatment effect on the treated (marginal risk difference [RD]) using propensity score matching. Results: Among participants, 25% experienced severe FI in the six months preceding the first time-point in the analytical sample and 5% concurrently reported receiving methadone treatment. Injection of opioids in the six months preceding the treatment and outcome measurements was much higher among those who received methadone treatment (39% vs. 12%). Among the treated participants, 97% had injected opioids in their lifetimes. After propensity score matching, the average risk of experiencing severe FI is 12.3 percentage-points lower among those receiving methadone treatment, compared to those who are not receiving treatment (marginal RD = -0.123, 95% CI = -0.230, 0.015). Conclusions: After adjustment for socioeconomic, sociodemographic, behavioural, and clinical confounders, methadone treatment is associated with a lower risk of severe FI. This finding suggests that methadone treatment may mitigate severe FI in this vulnerable subset of the HIV-positive population.
引用
收藏
页码:374 / 380
页数:7
相关论文
共 50 条
  • [21] ANALYSIS OF TREATMENT OF HEPATITIS C VIRUS IN HIV/HCV CO-INFECTION
    Fayyaz, Iqra
    Anzar, Atifa
    Jamil, Maryam
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (11): : 12597 - 12600
  • [22] Treatment of HIV/HCV co-infection in the DAA era
    Rockstroh, J. K.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S20 - S21
  • [23] HIV/HCV Co-infection: Overcoming Barriers to Treatment
    Gross, Chloe
    Akoth, Elizabeth
    Price, Angie
    Kattakuzhy, Sarah
    Silk, Rachel
    Rosenthal, Elana
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2016, 27 (04): : 524 - 529
  • [24] Predicting fatal drug poisoning among people living with HIV-HCV co-infection
    Bedard, Melanie
    Moodie, Erica E. M.
    Cox, Joseph
    Gill, John
    Walmsley, Sharon
    Martel-Laferriere, Valerie
    Cooper, Curtis
    Klein, Marina B.
    CANADIAN LIVER JOURNAL, 2025, 0 (AOP):
  • [25] Impact of Food Insecurity on Depressive Symptoms Among HIV-HCV Co-infected People
    Aibibula, Wusiman
    Cox, Joseph
    Hamelin, Anne-Marie
    Moodie, Erica E. M.
    Naimi, Ashley I.
    McLinden, Taylor
    Klein, Marina B.
    Brassard, Paul
    AIDS AND BEHAVIOR, 2017, 21 (12) : 3464 - 3472
  • [26] Recent Advances in the Treatment of HIV/HBV and HIV/HCV Co-Infection
    Masgala, A.
    Bonovas, S.
    Nikolopoulos, G. K.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (09) : 890 - 904
  • [27] Direct Acting Antivirals in HIV-HCV Co-infection: A Community Based Retrospective Cohort Study
    Gayam, Vijay
    Mukhtar, Osama
    Khalid, Mazin
    Garlapati, Pavani
    Sherigar, Jagannath
    Khan, Arifa
    Mohanty, Smruti
    Mansour, Mohammed
    Rangaraju, Ayyappa Mysore
    Budhathoki, Nibash
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S377 - S377
  • [28] Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort
    Cox, Joseph
    Maurais, Emilie
    Hu, Lina
    Moodie, Erica E. M.
    Law, Stephanie
    Bozinoff, Nikki
    Potter, Martin
    Rollet, Kathleen
    Hull, Mark
    Tyndall, Mark
    Cooper, Curtis
    Gill, John
    Saeed, Sahar
    Klein, Marina B.
    DRUG AND ALCOHOL DEPENDENCE, 2014, 137 : 121 - 128
  • [29] HCV treatment in children and young adults with HIV/HCV co-infection in Europe
    Turkova, Anna
    Giacomet, Vania
    Goetghebuer, Tessa
    Miloenko, Milana
    Nicolini, Laura Ambra
    Noguera-Julian, Antoni
    Rojo, Pablo
    Volokha, Alla
    Indolfi, Giuseppe
    Giaquinto, Carlo
    Thorne, Claire
    JOURNAL OF VIRUS ERADICATION, 2015, 1 (03) : 179 - 184
  • [30] Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel
    Soriano, V
    Sulkowski, M
    Bergin, C
    Hatzakis, A
    Cacoub, P
    Katlama, C
    Cargnel, A
    Mauss, S
    Dieterich, D
    Moreno, S
    Ferrari, C
    Poynard, T
    AIDS, 2002, 16 (06) : 813 - 828